Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tezacitabine +/- 5-FU in Advanced Esophageal or Gastric Cancer
NCT00054873Phase 2Completed
- Sponsor
- Chiron Corporation
- Start
- Nov 2003
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of tezacitabine in esophageal adenocarcinoma (EAC), gastric adenocarcinoma, sponsored by Chiron Corporation. Started Nov 2003; status: completed.
02
Drugs
tezacitabine
03
Conditions
esophageal adenocarcinoma (EAC)gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00054873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00054873.